Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell

Published:2019-12 Issue: Volume:239 Page:117010
ISSN:0024-3205
Container-title:Life Sciences
language:en
Short-container-title:Life Sciences

Author:

He Qian,Xia Xuan,Yao Kecheng,Zeng Jun,Wang Wei,Wu Qiong,Tang Renmin,Zou Xiulan

Funder

Scientific Research Project of Health Commission of Hubei Province

Medical and Health Research Project of Yichang

Young Scientist foundation of Hubei Health and Family Planning Commission

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference40 articles.

1. Past, present and future perspectives in nonalcoholic fatty liver disease;Sanyal;Nat. Rev. Gastroenterol. Hepatol.,2019

2. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease;Samuel;J. Biol. Chem.,2004

3. IKK-beta links inflammation to obesity-induced insulin resistance;Arkan;Nat. Med.,2005

4. Inflammation, stress, and diabetes;Wellen;J. Clin. Investig.,2005

5. Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta;Yuan;Science,2001

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure;Neurotherapeutics;2024-07

2. The gut-liver axis: emerging mechanisms and therapeutic approaches for nonalcoholic fatty liver disease and type 2 diabetes mellitus;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-11

3. Linking fatty liver diseases to hepatocellular carcinoma by hepatic stellate cells;Journal of the National Cancer Center;2024-03

4. Atypical inflammatory kinase IKBKE phosphorylates and inactivates FoxA1 to promote liver tumorigenesis;Science Advances;2024-02-09

5. A phosphodiesterase 4 (PDE4) inhibitor, amlexanox, reduces neuroinflammation and neuronal death after pilocarpine-induced seizure;2023-08-24

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3